Hebang Bio addresses tax payment, schedules investor briefing

Sichuan Hebang Biotechnology Co., Ltd. announced it has completed the payment of RMB 71,473,969.37 for corporate income tax and late payment fees for the period from January 1 to December 31, 2023. This self-declared tax adjustment, resulting from an internal review, is not subject to administrative penalties. The company stated the payment will be recorded as an expense in 2025, impacting its net profit for the year by the same amount.

In a related announcement, Sichuan Hebang Biotechnology will host a 2025 half-year performance briefing on September 22, 2025, from 16:00 to 17:00. The online event will allow investors to engage with company representatives, including controlling shareholder He Zhenggang and chief executive Zeng Xiaoping, to discuss the company's financial performance.

Investors can submit questions in advance from September 15 to September 19, 2025. The company confirmed this tax payment is not a prior period accounting error and will not require restating previous financial reports.